Consultations - Public Health - European Commission

Filter by

Medicinal products - Consultations (76)

RSS

Status: Closed

Stakeholders’ Consultation on EudraLex Volume 4 - Good Manufacturing Practice Guidelines: Chapter 1

Opening date: 3 September 2025
Deadline: 3 December 2025, 23:59 (CET)

Status: Closed

Stakeholders’ Consultation on EudraLex Volume 4 - Good Manufacturing Practice Guidelines: Chapter 4, Annex 11 and New Annex 22

Opening date: 7 July 2025
Deadline: 7 October 2025, 23:59 (CEST)

Status: Closed

Revision of the EU general pharmaceuticals legislation

Opening date: 28 September 2021
Deadline: 21 December 2021, 01:00 (CET)

Status: Closed

Targeted stakeholder consultation on the amendments to Commission Implementing Regulation (EU) 520/2012 on pharmacovigilance activities

Opening date: 31 August 2021
Deadline: 15 October 2021, 02:00 (CEST)

Status: Closed

Medicines for children & rare diseases – updated rules

Opening date: 7 May 2021
Deadline: 30 July 2021, 02:00 (CEST)

Status: Closed

Structured Dialogue initiative - Recruitment

Opening date: 10 March 2021
Deadline: 19 March 2021, 01:00 (CET)

Status: Closed

Impact assessment – EU legislation on medicines for rare diseases and paediatric medicines

Opening date: 24 November 2020
Deadline: 5 January 2021, 02:00 (CET)

Status: Closed

Pharmaceuticals – safe and affordable medicines (new EU strategy)

Opening date: 16 June 2020
Deadline: 15 September 2020, 02:00 (CEST)

Status: Closed

Targeted stakeholder consultation on the pilot project ‘Market Launch Intentions of Centrally Authorised Products’

Opening date: 22 June 2020
Deadline: 22 July 2020, 02:00 (CEST)

Status: Closed

Pharmaceutical Strategy Roadmap

Opening date: 2 June 2020
Deadline: 7 July 2020, 02:00 (CEST)

Status: Closed

Targeted stakeholders' consultation on Annex 21: Importation of medicinal products, of the Eudralex volume 4

Opening date: 20 March 2020
Deadline: 20 June 2020, 02:00 (CEST)

Status: Closed

Second targeted stakeholders' consultation on the revision of Annex 1, on manufacturing of sterile medicinal products, of Eudralex volume 4

Opening date: 20 February 2020
Deadline: 20 May 2020, 02:00 (CEST)

Status: Closed

Targeted consultation on the guideline on the format and content of applications for designation as orphan medicinal products and on the transfer of designations from one

Opening date: 29 January 2019
Deadline: 28 April 2019, 02:00 (CEST)

Status: Closed

Public consultation on legislation on medicines for children and rare diseases

Opening date: 18 October 2018
Deadline: 4 January 2019, 01:00 (CET)

Status: Closed

Targeted stakeholder consultation on the draft Guidelines on Good Clinical Practice for Advanced Therapy Medicinal Products

Opening date: 1 August 2018
Deadline: 31 October 2018, 01:00 (CET)

Status: Closed

Targeted stakeholder consultation on duplicate marketing authorisations for biological medicinal products

Opening date: 18 May 2018
Deadline: 10 September 2018, 02:00 (CEST)

Status: Closed

Study supporting the Evaluation of the European Medicines Agency Fee System

Opening date: 2 May 2018
Deadline: 2 August 2018, 02:00 (CEST)

Status: Closed

Targeted stakeholders consultation on the revision of annex 1, on manufacturing of sterile medicinal products, of the Eudralex volume 4

Opening date: 20 December 2017
Deadline: 20 March 2018, 01:00 (CET)

Status: Closed

Targeted stakeholder consultation on the revised guidelines on excipients in the labelling and package leaflet of medicinal products for human use

Opening date: 27 February 2017
Deadline: 22 May 2017, 02:00 (CEST)

Status: Closed

Targeted stakeholder consultation on the experience acquired with the Paediatric Regulation

Opening date: 15 November 2016
Deadline: 20 February 2017, 01:00 (CET)